Prevention of osteoporosis should be considered before a bone break occurs, and many patients at risk for the chronic bone condition may benefit from pharmacologic options. "Most current guidelines ...

Treatments for postmenopausal osteoporosis were generally misaligned with current guidelines among women at very high risk for fracture.

Not all osteoporosis medications work the same, and that's especially true for the small class of osteoanabolic agents. Only three approved drugs belong to this category -- teriparatide, abaloparatide ...